Our mission is to provide accessible outsourcing opportunities without sacrificing quality.
USA FDA 503A compounding facility with formulation and end-to-end clinical trial solutions toward commercialization.
​
Whether your project is an academic research or IP still in research, we’re committed to assisting and supporting your project with the right outcome.
Optimized & Dedicated access
Now offering formulation, testing, and dispensing capabilities
Investigational Drug Service
Universal Compounding Pharmacy (UCRx) is a trusted 503A in delivering advanced solutions for decentralized clinical trials. With a strong commitment to supporting researchers, UCRx offers a comprehensive suite of specialized services, including the sourcing of investigational drugs and raw materials, custom compounding of unique dosage forms, and advanced packaging and dispensing solutions. Equipped with state-of-the-art primary and secondary engineering facility, along with certified investigational and compounding pharmacists, our team ensures the formulation of a wide range of pharmaceutical products, providing the adaptability required for investigational drug protocols.
​
Currently, UCRx supports numerous clinical trials across academic institutions, fostering robust partnerships with esteemed academic and research medical schools. With its track record and infrastructure, UCRx serves as a pivotal partner in advancing decentralized clinical trial methodologies, enhancing patient access to innovative therapies.
Every trial begins with a pharmacy consultant
Clinical Trial Drug Sourcing
Testing & Validation
Service
Outcomes
Access to big 3 national distributors for brand and generics.
Access to big 3 national distributors for Active Pharmaceutical Ingredients (APIs)
Onsite formulatio and compound all dosage forms when not available.
Lean Six-Sigma methodology applied to each production
Collaborate with FDA registered, DEA registered, and ISO 17025:2005 accredited for GMP and nonGMP testings
Method Development and Validation
Method Suitability Test
Sterility Method Suitability
Stability-Indicating Assay Study program.
USP compliant batch release testing programs
​
Pharmacist 24/7 On-Call
Emergency unblinding access
Telepharmacy patient consultation
Direct dispensing to patient or investigators
​IP Return & reconcilcation
IP Destruction Service
Protocol Management & Randomization control.
​Each clinical trial is driven by an in-house project manager.
​Shipping and Dispensing with traceability.
Clinical Trial Drug Sourcing leverages USA Big 3 Drug distribution relationships to source drugs or APIs
Exceptional Access
broad access to the drugs a trial needs, anywhere in the USA
​continuous supply throughout the course of a trial
competitive pricing through drug wholesaling contracting
track-and-trace compliant
The Role of Certified Research Pharmacists at UCRx in Clinical Trials
Certified research pharmacists at UCRx are pivotal in the execution of clinical trials, serving as both scientific experts and operational specialists. They design and compound blinded drug formulations, meticulously tailored to the unique demands of each study. By ensuring the integrity and stability of investigational drugs, these pharmacists uphold the rigorous standards required for clinical research while maintaining the critical blinding necessary to ensure unbiased results.
​
Through their expertise in formulation science, regulatory compliance, and quality assurance, UCRx pharmacists play an indispensable role in advancing clinical research. Their behind-the-scenes contributions help facilitate the development of innovative therapies, ultimately improving patient care and driving medical progress.
Investigational Drug Program at Universal Compounding Pharmacy
Decentralized Clinical Trials: Advancing New Therapies and Repurposing Existing Drugs
​
Henry Truong, PharmD, MS, serves as the Director of Investigational Drugs at Mariner Advanced Pharmacy in Redwood City and Universal Compounding Pharmacy in Signal Hill, CA. Since founding these pharmacies in 2011 and 2019 respectively, Dr. Truong has been instrumental in expanding their scope, transitioning from compounding pharmacist roles to launching and leading the Investigational Drug Service (IDS) division.
​
Dr. Truong’s pathway to becoming a research pharmacist evolved naturally through his early clinical experiences, which introduced him to investigational drug services. Collaborating with local academic researchers and supporting community patients further solidified his passion for advancing clinical trials. Today, he partners with prominent academic institutions and pharmaceutical companies to support clinical research.
​
Click here to explore sample trial projects.
​
Dr. Truong has contributed to numerous phase 1 and 2 trials alongside esteemed researchers. Among these, a groundbreaking trial investigates jacifusen, a novel drug aimed at treating a rare form of ALS in patients with the FUS gene mutation. This experimental therapy is delivered directly into the intrathecal space to target the disease at its source.
​
Phase 1 clinical trials, or early-phase studies, mark the initial testing of experimental drugs or treatments in human subjects. These trials prioritize safety evaluation, monitor side effects, determine optimal dosages, and identify the best method of administration—whether oral, intravenous, or injection. The goal is to understand how the treatment interacts with the human body.
​
"The rare ALS study excites me because it offers patients a potential last-resort treatment option," Dr. Truong shares.
​
Dr. Truong and his team pride themselves on being involved in every stage of clinical trials—from writing protocols and activating studies to dispensing medications and contributing to published results. "It’s incredibly satisfying to know that our work could lead to new treatment options for patients with limited or no alternatives," he adds.
